Main Symposia

Saturday 8 September
11.00 – 13.00

11.00
P. Fagerholm SWEDEN
Mechanisms of neovascularisation
11.15
D. Said UK
Clinical aspects and assessment of corneal vascularisation
11.30
Discussion
11.40
C. Cursiefen GERMANY
The medical management of corneal vascularisation
11.55
L. Fontana ITALY
The surgical management of corneal vascularisation in ocular surface disease
12.10
Discussion
12.20
J. Güell SPAIN
Pterygium and vascularisation: current concepts and therapeutic implications
12.35
B. Seitz GERMANY
Corneal vascularisation in HSV keratopathy: implications for transplantation
12.50
Discussion
13.00
End of session

14.00
S. Wolf SWITZERLAND
Does cataract surgery accelerate conversion to wet AMD?
14.15
F. Holz GERMANY
Prophylactic anti-VEGF therapy in high risk dry and wet AMD
at the time of cataract surgery?
14.30
Discussion
14.40
J. F. Korobelnik FRANCE
Are multifocal IOLs contraindicated in AMD?
14.55
F. Cuthbertson UK
Do blue filter IOLs work?
15.10
Discussion
15.20
F. Bandello ITALY
Diagnostic and treatment in diabetic macular oedema: an update
15.35
M. Wilkins UK
The intraocular telescope for AMD
15.50
Discussion
16.00
End of session

11.00
R. Kekunnaya INDIA
Do study design and surgical technique influence pediatric cataract study outcomes?
11.15
E. Wilson USA
Infant Aphakia Treatment Study
11.30
Discussion
11.40
C. Zetterström SWEDEN
Clinical factors affecting target refraction in pediatric cataract surgery
11.55
M.J. Tassignon BELGIUM
Which IOLs are best in children's eyes?
12.10
Discussion
12.20
M. O'Keefe IRELAND
Is there a role for phakic IOLs in the treatment of amblyopia?
12.35
W. Astle CANADA
Can the refractive surgeon help? PRK, LASEK and LASIK in children
12.50
Discussion
13.00
End of session

11.00
I. Pallikaris GREECE
Imaging and capturing technology: how does it work?
11.15
J. Stevens UK
Delivery systems: How do they function?
11.30
Real world clinical results and complications
F. Bucci USA (LensAR)
S. Daya UK (B&L Victus)
B. Dick GERMANY (Optimedica)
Z. Nagy HUNGARY (LensX Alcon)
12.00
Discussion
12.10
R. Lindstrom USA
When will it work in private practice: what does it take to make it work?
12.25
Discussion
12.35
R. Bellucci ITALY
When and how will it work in public practice?
12.50
Discussion
13.00
End of session

11.00
G. Auffarth GERMANY
The gold standards: IOLMaster 500 and LenStar
11.15
N. Rosa ITALY
IOL power calculation in premium IOLs: part I (Accommodative/multifocal)
11.30
Discussion
11.40
J. Aramberri SPAIN
IOL power calculation in premium IOLs: part II (Toric)
11.55
W. Haigis GERMANY
IOL power calculation after refractive surgery
12.10
Discussion
12.20
C. Carbonara ITALY
New tools for biometry
12.35
M. Mrochen SWITZERLAND
The future: customised eye models
12.50
Discussion
13.00
End of session

11.00
D. Spalton UK
How I avoid damaging the capsule
11.15
J. Holladay USA
How I always avoid refractive surprise
11.30
Discussion
11.40
R. Nuijts THE NETHERLANDS
How I avoid inducing astigmatism
11.55
C. Lobo PORTUGAL
How I avoid cystoid macular oedema
12.10
Discussion
12.20
L. Buratto ITALY
How I always avoid patient dissatisfaction
12.35
K. Pesudovs AUSTRALIA
I always evaluate patient benefits after cataract surgery
12.50
Discussion
13.00
End of session